Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q4 2020 Earnings

2NovConfirmed

Q1 2020

Q2 2020

Q3 2020

Q4 2020

-0.24

-0.07

0.1

0.27

Details

Expected EPS

0.2

Actual EPS

0.25

Surprise EPS

0.05

Surprise Percent

+25%

Description

Halozyme Therapeutics (HALO) has reported earnings of 0.25 per share for Q4 2020.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.